# Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.

> **NCT06283641** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 300 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT06283641
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-08
- **Primary completion:** 2025-01-13
- **Final completion:** 2025-01-13
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06283641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06283641, "Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06283641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*